A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results